Investor Presentaiton
2023 adjusted EPS (non-GAAP)
We cannot provide a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measure for Adjusted EPS* in 2023 without
unreasonable effort due to the uncertainty of timing of any gains or losses related to acquisitions & dispositions, the timing and magnitude of the financial impact related to
the mark-to-market of our remaining investment in GE HealthCare, AerCap and Baker Hughes, and the timing and magnitude of restructuring expenses. Although we have
attempted to estimate the amount of gains and restructuring charges for the purpose of explaining the probable significance of these components, this calculation involves a
number of unknown variables, resulting in a GAAP range that we believe is too large and variable to be meaningful.
2023 free cash flows & conversion (non-GAAP)
We cannot provide a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measure for free cash flows* in 2023 without
unreasonable effort due to the uncertainty of timing of taxes related to business sales.
* Non-GAAP Financial Measure
95
Gε
2023 GE INVESTOR CONFERENCE 121View entire presentation